85
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Prevalence of Protective Haplotypes of the SLCO1B1 Gene for Statin Transport in Mexican Populations

ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 533-540 | Received 13 Nov 2020, Accepted 16 Jul 2021, Published online: 22 Oct 2021

References

  • Sortica Vde A , OjopiEB , GenroJPet al. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians. Basic Clin. Pharmacol. Toxicol.110(5), 460–468 (2012).
  • Hubacek JA , DlouhaD , AdámkovaVet al. Possible gene-gender interaction between the SLCO1B1 polymorphism and statin treatment efficacy. Neuro. Endocrinol. Lett.33(2), 22–25 (2012).
  • Niemi M , PasanenMK , NeuvonenPJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol. Rev.63(1), 157–181 (2011).
  • Li JH , SuchindranS , ShahSH , KrausWet al. SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization. Pharmacogenomics16(5), 449–458 (2015).
  • Ramsey LB , JohnsonSG , CaudleKEet al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin. Pharmacol. Ther.96(4), 423–428 (2014).
  • Prado Y , SaavedraN , ZambranoTet al. SLCO1B1 c.388A>G polymorphism is associated with HDL-C levels in response to atorvastatin in Chilean individuals. Int. J. Mol. Sci.16(9), 20609–20619 (2015).
  • Rodrigues AC , PerinPM , PurimSGet al. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. Int. J. Mol. Sci.12(9), 5815–5827 (2011).
  • Wilke RA , RamseyLB , JohnsonSGet al. The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin. Pharmacol. Ther.92(1), 112–117 (2012).
  • León-Cachón RBR , Ascacio-MartínezJA , Gamino-PeñaMEet al. A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers. BMC Cancer16, 74 (2016).
  • Santos PC , SoaresRA , NascimentoRMet al. SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: amerindians as a high risk ethnic group. BMC Med. Genet.12, 136 (2011).
  • Rubi-Castellanos R , Anaya-PalafoxM , Mena-RojasEet al. Genetic data of 15 autosomal STRs (Identifiler kit) of three Mexican Mestizo population samples from the states of Jalisco (West), Puebla (Center), and Yucatan (Southeast). Forensic Sci. Int. Genet.3(3), e71–e76 (2009).
  • Rangel-Villalobos H , Martínez-SevillaVM , Martínez-CortésGet al. Importance of the geographic barriers to promote gene drift and avoid pre- and post-Columbian gene flow in Mexican native groups: evidence from forensic STR loci. Am. J. Phys. Anthropol.160(2), 298–316 (2016).
  • Peakall R , SmousePE. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research – an update. Bioinformatics28(19), 2537–2739 (2012).
  • Excoffier L , LavalG , SchneiderS. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol. Bioinform. Online1, 47–50 (2005).
  • Yoo J , LeeY , KimYet al. SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis. BMC Bioinformatics9, 290 (2008).
  • Moreno-Estrada A , GignouxCR , Fernández-LópezJCet al. Human genetics . The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science344(6189), 1280–1285 (2014).
  • Nagar SD , MorenoAM , NorrisETet al. Population pharmacogenomics for precision public health in Colombia. Front. Genet.10, 241 (2019).
  • Dong OM , LiA , SuzukiOet al. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients. Pharmacogenomics19(9), 771–782 (2018).
  • Favela-Mendoza AF , Rangel-VillalobosH , Fricke-GalindoIet al. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms. Mol. Biol. Rep.45(6), 2525–2533 (2018).
  • Yang NN , MazieS , BraviCet al. Contrasting patterns of Nuclear and mtDNA diversity in Native American populations. Ann. Hum. Genet.74, 525–538 (2010).
  • Peyser B , PerryEP , SinghKet al. Effects of delivering SLCO1B1 pharmacogenetic information in randomized trial and observational settings. Circ. Genom. Precis. Med.11(9), e002228 (2018).
  • Chatzizisis YS , KoskinasKC , MisirliGet al. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf.33(3), 171–187 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.